Company Profile
BOAN BIOTECH
Description
Shandong Boan Biotechnology Co., Ltd. develops, manufactures, and commercializes biologics in Mainland China and internationally. Its commercialized products include Boyounuo (BA1101) bevacizumab injection for the treatment of metastatic or recurrent non-small cell lung cancer (NSCLC), recurrent glioblastoma, epithelial ovarian, fallopian tube or primary peritoneal cancer, and cervical cancer; and Boyoubei BA6101, a human immunoglobulin G2 monoclonal antibody for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The company develops BA1102 denosumab injection to treat patients with skeletal-related events caused by multiple myeloma and bone metastases from solid tumors, as well as giant cell tumour of bone; BA5101 dulaglutide injection indicated for glycemic control in adults with type-2 diabetes; and BA9101 aflibercept intravitreous injection to treat neovascular wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity. It also develops BA1104 to treat patients with melanoma, NSCLC, malignant pleural mesothelioma, RCC, classical hodgkin lymphoma, SCCHN, urothelial carcinoma, colorectal cancer, hepatocellular carcinoma, esophageal and gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma; BA2101, a human monoclonal antibody that targets interleukin-4 receptor subunit alpha; BA1202, a CEA/CD3 bispecific antibody; BA1106, a non-IL-2 blocking anti-CD25 antibody; BA1301: an antibody drug conjugate (ADC) candidate that targets Claudin 18.2; BA1105, a recombinant anti-Claudin 18.2 fully human IgG1 monoclonal antibody; and BA1302, a novel CD228-directed ADC. The company was founded in 2013 and is headquartered in Yantai, China. Shandong Boan Biotechnology Co., Ltd. is a subsidiary of Shandong Luye Pharmaceutical Co., Ltd.
Reports
This company has 3 ESG reports available.
ESG Performance Overview
Select a KPI indicator to view performance trend
KPI Indicators
A1.1 Emission Types and Data
9 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| SOₓ Emissions | 2 | |
| NOₓ Emissions | 2 | |
| PM2.5 Emissions | 2 | |
| PM10 Emissions | 2 | |
| Airborne Particulate Matter (PM) Emissions | 1 |
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
19 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total GHG Emissions Intensity (By Revenue) | 5 | |
| Total GHG Emissions | 5 | |
| Direct GHG Emissions (Scope 1) | 1 | |
| Indirect Energy Emissions (Scope 2) | 5 | |
| GHG Emissions from Purchased Electricity | 3 |
A1.3 Hazardous Waste
10 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total Hazardous Waste Intensity (By Revenue) | 5 | |
| Total Hazardous Waste | 5 |
A1.4 Non-Hazardous Waste
12 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Non-Hazardous Waste Recycled | 4 | |
| Paper Waste | 3 | |
| Total Non-Hazardous Waste Intensity (By Revenue) | 5 |
A2.1 Energy Consumption
39 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Purchased Electricity Intensity (By Revenue) | 5 | |
| Direct Energy Intensity (By Revenue) | 2 | |
| Indirect Energy Intensity (By Revenue) | 5 | |
| Total Direct Energy Consumption | 3 | |
| Gasoline Consumption | 4 | |
| Total Indirect Energy Consumption | 5 | |
| Purchased Electricity | 5 | |
| Purchased Steam | 10 |
A2.2 Water Consumption
20 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total Wastewater Discharge | 5 | |
| Water Consumption | 5 | |
| Water Consumption Intensity (By Revenue) | 5 | |
| Wastewater Discharge Intensity | 5 |
A2.5 Total Packaging Material Used
10 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Packaging Materials Consumed | 5 | |
| Packaging Material Intensity (By Revenue) | 5 |
B1.1 Amount and Distribution of Workforce
57 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Total Employees | 3 | |
| Number of Male Employees | 3 | |
| Number of Female Employees | 3 | |
| Percentage of Male Employees | 3 | |
| Percentage of Female Employees | 3 | |
| Number of Full-time Employees | 3 | |
| Number of Part-time Employees | 3 | |
| Percentage of Full-time Employees | 3 | |
| Percentage of Part-time Employees | 3 | |
| Number of Employees Aged Below 30 | 3 | |
| Number of Employees Aged 30-50 | 3 | |
| Number of Employees Aged Above 50 | 3 | |
| Percentage of Employees Aged Below 30 | 3 | |
| Percentage of Employees Aged 30-50 | 3 | |
| Percentage of Employees Aged Above 50 | 3 | |
| Number of Employees in Mainland China | 3 | |
| Number of Employees in Overseas | 3 | |
| Percentage of Employees in Mainland China | 3 | |
| Percentage of Employees in Overseas | 3 |
B1.2 Employee Turnover Rate
14 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Turnover Rate of Female Employees | 3 | |
| Turnover Rate of Male Employees | 2 | |
| Turnover Rate of Employees Aged Below 30 | 1 | |
| Turnover Rate of Employees Aged 30-50 | 1 | |
| Turnover Rate of Employees Aged Above 50 | 1 | |
| Turnover Rate of Employees in Mainland China | 3 | |
| Turnover Rate of Employees in Overseas | 3 |
B2.1 Number and Rate of Work-related Fatalities
12 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Work-related Fatalities | 6 | |
| Work-related Fatalities Rate | 6 |
B2.2 Lost Days Due to Work Injury
6 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Lost Days Due to Work-related Injuries | 6 |
B2.3 Occupational Health and Safety Measures Adopted
3 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of People Receiving Training on Work Safety | 3 |
B3.1 The Percentage of Employees Trained
14 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Percentage of Employees Trained | 2 | |
| Percentage of Trained Male Employees | 3 | |
| Percentage of Trained Female Employees | 3 | |
| Percentage of Trained Senior Management | 3 | |
| Percentage of Trained General Employees | 3 |
B3.2 Average Training Hours Completed per Employee
19 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Total Training Hours | 2 | |
| Average Training Hours (Male) | 3 | |
| Average Training Hours (Female) | 3 | |
| Average Training Hours (Senior Management) | 3 | |
| Average Training Hours (Middle Management) | 3 | |
| Average Training Hours (General Staff) | 3 | |
| Average Training Hours (Director and Above) | 2 |
B5.1 Number of Suppliers by Geographical Region
2 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Total Suppliers | 1 | |
| Number of Suppliers in Overseas | 1 |
B7.3 Anti-corruption Training
2 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Number of Directors and Management Attendance for Anti-corruption Training | 2 |
General
5 Data Points| Indicator | Data Points | Actions |
|---|---|---|
| Purchased Steam Intensity (By Revenue) | 4 | |
| Gasoline Consumption Intensity (By Revenue) | 1 |
ESG Reports
| Year | Report Title | Publication Date | Raw KPIs | Standard KPIs | Processed | Actions |
|---|---|---|---|---|---|---|
| 2024 | 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2025-04-29 | 186 | 95 | Yes | |
| 2023 | 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2024-04-29 | 199 | 98 | Yes | |
| 2022 | 2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 2023-04-25 | 153 | 60 | Yes |